TY - JOUR
T1 - TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions
AU - Cairns, Nigel J.
AU - Neumann, Manuela
AU - Bigio, Eileen H.
AU - Holm, Ida E.
AU - Troost, Dirk
AU - Hatanpaa, Kimmo J.
AU - Foong, Chan
AU - White, Charles L.
AU - Schneider, Julie A.
AU - Kretzschmar, Hans A.
AU - Carter, Deborah
AU - Taylor-Reinwald, Lisa
AU - Paulsmeyer, Katherine
AU - Strider, Jeffrey
AU - Gitcho, Michael
AU - Goate, Alison M.
AU - Morris, John C.
AU - Mishra, Manjari
AU - Kwong, Linda K.
AU - Stieber, Anna
AU - Xu, Yan
AU - Forman, Mark S.
AU - Trojanowski, John Q.
AU - Lee, Virginia M.Y.
AU - Mackenzie, Ian R.A.
PY - 2007/7
Y1 - 2007/7
N2 - TAR DNA-buiding protein 43 (TDP-43) is a major pathological protein of sporadic and familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions (FTLD-U) with or without motor neuron disease (MND). Thus, TDP-43 defines a novel class of neurodegenerative diseases called TDP-43 proteinopathies. We performed ubiquitin and TDP-43 immunohistochemistry on 193 cases of familial and sporadic FTLD with or without MND. On selected cases, immunoelectron microscopy and biochemistry were performed. Clinically defined frontotemporal dementias (FTDs) included four groups: 1) familial FTD with mutations in progranulin (n = 36), valosin containing protein (n = 5), charged multivesicular body protein 2B (n = 4), and linked to chromosome 9p (n = 7); 2) familial cases of FTD with unknown gene association (n = 29); 3) sporadic FTD (n = 72); and 4) familial and sporadic FTD with MND (n = 40). Our studies confirm that the spectrum of TDP-43 proteinopathies includes most cases of sporadic and familial FTLD-U with and without MND and expand this disease spectrum to include reported families with FTD linked to chromosome 9p but not FTD with charged multivesicular body protein 2B mutations. Thus, despite significant clinical, genetic, and neuropathological heterogeneity of FTLD-U, TDP-43 is a common pathological substrate underlying a large subset of these disorders, thereby implicating TDP-43 in novel and unifying mechanisms of FTLD pathogenesis.
AB - TAR DNA-buiding protein 43 (TDP-43) is a major pathological protein of sporadic and familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions (FTLD-U) with or without motor neuron disease (MND). Thus, TDP-43 defines a novel class of neurodegenerative diseases called TDP-43 proteinopathies. We performed ubiquitin and TDP-43 immunohistochemistry on 193 cases of familial and sporadic FTLD with or without MND. On selected cases, immunoelectron microscopy and biochemistry were performed. Clinically defined frontotemporal dementias (FTDs) included four groups: 1) familial FTD with mutations in progranulin (n = 36), valosin containing protein (n = 5), charged multivesicular body protein 2B (n = 4), and linked to chromosome 9p (n = 7); 2) familial cases of FTD with unknown gene association (n = 29); 3) sporadic FTD (n = 72); and 4) familial and sporadic FTD with MND (n = 40). Our studies confirm that the spectrum of TDP-43 proteinopathies includes most cases of sporadic and familial FTLD-U with and without MND and expand this disease spectrum to include reported families with FTD linked to chromosome 9p but not FTD with charged multivesicular body protein 2B mutations. Thus, despite significant clinical, genetic, and neuropathological heterogeneity of FTLD-U, TDP-43 is a common pathological substrate underlying a large subset of these disorders, thereby implicating TDP-43 in novel and unifying mechanisms of FTLD pathogenesis.
UR - http://www.scopus.com/inward/record.url?scp=34547663747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547663747&partnerID=8YFLogxK
U2 - 10.2353/ajpath.2007.070182
DO - 10.2353/ajpath.2007.070182
M3 - Article
C2 - 17591968
AN - SCOPUS:34547663747
SN - 0002-9440
VL - 171
SP - 227
EP - 240
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 1
ER -